Skip to content
    Reviews

    Improving Voice Outcomes After Transoral Laser Surgery for Early Glottic Cancer: A Systematic Review

    Koscak et alOtolaryngology–Head and Neck Surgery

    A systematic review evaluating interventions to optimize vocal function following transoral laser microsurgery (TLM) for early-stage (T1-T2) glottic squamous cell carcinoma identified structured voice therapy and selective surgical modifications as the most evidence-supported approaches. Across 13 included studies encompassing four intervention domains—voice therapy, intraoperative surgical modifications, injection augmentation, and postoperative reconstruction—voice rehabilitation interventions demonstrated varied efficacy.
    Voice therapy produced substantial subjective improvement, highlighted by a randomized controlled trial showing a significant reduction in Voice Handicap Index-30 (VHI-30) scores (-31.5 points) compared to controls (+3.35 points, P < .01). For intraoperative approaches, a modified Type III cordectomy that preserves the inferior vocalis muscle led to glottic closure rates of 85% versus 33% with classical resection (P = .026), achieving vocal outcomes on par with less extensive Type I and II resections in patients with favorable tumor locations.
    Conversely, evidence does not currently support routine injection augmentation, as randomized data showed no benefit for contralateral hyaluronic acid, and studies evaluating ipsilateral autologous fat yielded inconsistent outcomes. Postoperative vocal fold reconstruction techniques demonstrated functional gains only in select individuals and remain constrained by a lack of standardized implant materials and comparative control groups.

    Key Takeaways

    • Structured voice therapy significantly improved Voice Handicap Index-30 (VHI-30) scores compared with controls in a randomized controlled trial (-31.5 vs +3.35 points, P < .01).
    • Modified Type III cordectomy preserving the inferior vocalis muscle achieved an 85% complete glottic closure rate compared to 33% with classical resection (P = .026), yielding voice outcomes comparable to Type I/II resections.
    • Contralateral hyaluronic acid injection augmentation showed no benefit over controls in a randomized trial, while ipsilateral autologous fat demonstrated mixed outcomes.
    Read the original sourceOtolaryngology–Head and Neck Surgery